Easier pill for transplant kids? study tests new daily dose
Disease control
Completed
This study tested if switching children with stable organ transplants from a twice-daily anti-rejection pill (Prograf) to a new once-daily version (Advagraf) was safe and kept the right amount of medicine in their blood. It involved 81 children who had received a heart, kidney, l…
Phase: PHASE2 • Sponsor: Astellas Pharma Europe Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC